| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Inglis Tiffany Eul Davis serves as a Chief Medical Officer at SERA. Across recent SEC filings that breaks down to 0 buys and 3 sells. Those positions are worth an estimated $170K at current prices.
The biggest single holding is SERA (~$170K) as Chief Medical Officer. The recent filings there lean toward selling, a net 8,872 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 12, 2026 | SERA Sera Prognostics, Inc. | Chief Medical Officer | Sell | 8,024 | $2.03 | $16,288.72 | -8.8% | - | - | |
| Sep 10, 2026 | SERA Sera Prognostics, Inc. | Chief Medical Officer | Sell | 486 | $2.00 | $972.00 | -0.5% | - | - | |
| Jun 11, 2026 | SERA Sera Prognostics, Inc. | Chief Medical Officer | Sell | 362 | $2.01 | $727.62 | -0.4% | +3.6% | - |